A prostate gland volume of more than 75 cm3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer. (Q52905657)

9 May 2018

title

A prostate gland volume of more than 75 cm3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer. (English)

1 reference

9 May 2018

1 reference

D'Amico AV

1

1 reference

9 May 2018

Whittington R

2

1 reference

9 May 2018

Malkowicz SB

3

1 reference

9 May 2018

Schultz D

4

1 reference

9 May 2018

Tomaszewski JE

5

1 reference

9 May 2018

Wein A

6

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 October 1998

1 reference

9 May 2018

published in

Urology

1 reference

9 May 2018

volume

52

1 reference

9 May 2018

page(s)

631-636

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

Relationship between prostatic epithelial volume and serum prostate-specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

Human benign prostatic hyperplasia: A stromal disease? New perspectives by quantitative morphology

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

Correlation of pathologic findings with progression after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

Outcome of sextant biopsy according to gland volume

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

The influence of prostate size on cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

Immunohistochemical determination of age related proliferation rates in normal and benign hyperplastic human prostates.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

Cell kinetic in epithelium and stroma of benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900228-3

7 January 2021

10.1016/S0090-4295(98)00228-3

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

9763083

1 reference

9 May 2018